SCHEMBL14004126

SCHEMBL14004126

CNC(=O)CSC[18F]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15945376 0.84 KMT2A (0.48) —
SCHEMBL14004129 0.81 — —
SCHEMBL14559794 0.77 — —
SCHEMBL17346842 0.75 KMT2A (0.43) —
SCHEMBL26747622 0.75 CYP2D6 (0.60) —
SCHEMBL10083524 0.75 HSD17B10 (0.44) —
SCHEMBL20852576 0.74 — —
SCHEMBL18540716 0.73 — —
SCHEMBL21300823 0.71 KMT2A (0.41) —
SCHEMBL27787238 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080292547-A1 Novel Imaging Agents for Fibrosis TOLLESHAUG HELGE 2008-11-27 — — US disclosed
US-20080279765-A1 Novel Imaging Agents for Fibrosis CHETTIBI SALAH 2008-11-13 — — US disclosed
US-20080274052-A1 RADIOFLORINATION METHODS GE HEALTHCARE LIMITED (GB) 2008-11-06 — — US disclosed
US-7368474-B2 Radiofluorination methods GE HEALTHCARE LIMITED (GB) 2008-05-06 — — US disclosed
Send feedback